Author
Listed:
- Anne-Elisabeth Petit
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
- Nathalie Demotte
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
- Benoît Scheid
(TIPs, Université Libre de Bruxelles)
- Claude Wildmann
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
- René Bigirimana
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
- Monica Gordon-Alonso
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
- Javier Carrasco
(Grand Hôpital de Charleroi)
- Salvatore Valitutti
(INSERM, UMR 1043, Centre de Physiopathologie de Toulouse Purpan)
- Danièle Godelaine
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
- Pierre van der Bruggen
(Ludwig Institute for Cancer Research, WELBIO and de Duve Institute, Université catholique de Louvain)
Abstract
Surface galectin has been shown to contribute to dysfunctions of human tumour-infiltrating lymphocytes (TILs). We show here that galectin-covered CD8 TILs produce normal amounts of intracellular cytokines, but fail to secrete them because of defective actin rearrangements at the synapse. The non-secreting TILs also display reduced adhesion to their targets, together with defective LFA-1 recruitment and activation at the synapse. These defects are relieved by releasing surface galectin. As mild LFA-1 blockade on normal blood T cells emulate the defects of galectin-covered TILs, we conclude that galectin prevents the formation of a functional secretory synapse by preventing optimal LFA-1 triggering. Our results highlight a major secretory defect of TILs that is not revealed by widely used intracellular cytokine immunomonitoring assays. They also provide additional insights into the T-cell response, by showing that different thresholds of LFA-1 triggering are required to promote the intracellular production of cytokines and their secretion.
Suggested Citation
Anne-Elisabeth Petit & Nathalie Demotte & Benoît Scheid & Claude Wildmann & René Bigirimana & Monica Gordon-Alonso & Javier Carrasco & Salvatore Valitutti & Danièle Godelaine & Pierre van der Bruggen, 2016.
"A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion,"
Nature Communications, Nature, vol. 7(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12242
DOI: 10.1038/ncomms12242
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12242. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.